Daclatasvir 30 mg, 60 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 30 mg, 60 mg
Reference Brands: Daklinza® (US & EU)
Category: Hepatitis
Daclatasvir is an effective oral antiviral used to treat chronic Hepatitis C infection by inhibiting the NS5A protein critical for viral replication. Available as 30 mg and 60 mg tablets, it is manufactured under EU-GMP and USFDA standards. Widely used in combination therapies, Daclatasvir supports broad HCV genotype coverage. Ideal for B2B supply, hospital tenders, and licensing, it comes with comprehensive regulatory dossiers enabling quick registration in global markets.
Product Description: Daclatasvir is a potent direct-acting antiviral (DAA) used in the treatment of chronic Hepatitis C virus (HCV) infection. It functions by selectively inhibiting the NS5A protein, a key factor in viral replication and assembly. Available as oral tablets in strengths of 30 mg and 60 mg, Daclatasvir is commonly used in combination with Sofosbuvir or other antivirals for broad genotype coverage. Manufactured under strict EU-GMP and USFDA standards, it is suitable for B2B supply, hospital tenders, and licensing. Comprehensive regulatory dossiers support fast market registration and global distribution.
Daclatasvir — third party manufacturing & bulk supply
Daclatasvir 30 mg, 60 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Daclatasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Daclatasvir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsRibavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View DetailsAdefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsTenofovir Alafenamide (Taf)
Strength:
25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy (EU & US), Genvoya (India)
View DetailsQuick Response Guaranteed | Verified Suppliers